RecruitingNot Applicable

Compassionate Access of the Miltenyi Device for CD34+ Cell Selection

United States200 participantsStarted 2015-05-06

Plain-language summary

Objectives: Primary Objective To provide compassionate access to the Miltenyi device for CD34+ cell infusions to patients who experience poor graft function after stem cell transplantation (SCT).

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: 1\) Patients who have poor or no graft function post stem cell transplantation. Exclusion Criteria: N/A

What they're measuring

Increased Graft Function after Stem Cell Transplantation (SCT)

Timeframe: 4 weeks

Trial details

NCT IDNCT02438904

SponsorM.D. Anderson Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-05-01

Contact for this trial

Elizabeth Shpall, MD

713-745-2161 eshpall@mdanderson.org

View on ClinicalTrials.gov More Blood And Marrow Transplantation trials